Safety of Long-acting Beta-agonists: Urgent Need to Clear the Air Remains

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2009 Jan 2

PMID 19118222

Citations 6

Authors

R Beasley

F D Martinez

A Hackshaw

K F Rabe

P J Sterk

R Djukanovic

Affiliations

Soon will be listed here.

Citing Articles

Patterns of bronchodilator therapy in asthmatic outpatients.

Aryani T, Rahmawati R, Cintyadewi N, Puspitasari A, Rasyid A, Samirah J Public Health Afr. 2023; 14(Suppl 1):2533.

PMID: 37492548 PMC: 10365643. DOI: 10.4081/jphia.2023.2533.

Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies.

Altawalbeh S, Thorpe C, Zgibor J, Kane-Gill S, Kang Y, Thorpe J J Am Geriatr Soc. 2016; 64(8):1592-600.

PMID: 27351988 PMC: 7961814. DOI: 10.1111/jgs.14235.

Asthma.

Martinez F, Vercelli D Lancet. 2013; 382(9901):1360-72.

PMID: 24041942 PMC: 11753400. DOI: 10.1016/S0140-6736(13)61536-6.

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Decramer M, Hanania N, Lotvall J, Yawn B Int J Chron Obstruct Pulmon Dis. 2013; 8:53-64.

PMID: 23378756 PMC: 3558319. DOI: 10.2147/COPD.S39018.

The role of tiotropium in the management of asthma.

Park H Asia Pac Allergy. 2012; 2(2):109-14.

PMID: 22701860 PMC: 3345323. DOI: 10.5415/apallergy.2012.2.2.109.

References

DiSantostefano R, Davis K, Yancey S, Crim C . Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid- and salmeterol-containing products. Ann Allergy Asthma Immunol. 2008; 100(6):558-65. DOI: 10.1016/S1081-1206(10)60048-8. View

Martinez F . Safety of long-acting beta-agonists--an urgent need to clear the air. N Engl J Med. 2005; 353(25):2637-9. DOI: 10.1056/NEJMp058299. View

Wijesinghe M, Perrin K, Harwood M, Weatherall M, Beasley R . The risk of asthma mortality with inhaled long acting beta-agonists. Postgrad Med J. 2008; 84(995):467-72. DOI: 10.1136/pgmj.2007.067165. View

Yates D, Kharitonov S, Barnes P . An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Am J Respir Crit Care Med. 1996; 154(6 Pt 1):1603-7. DOI: 10.1164/ajrccm.154.6.8970342. View

Rea H, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland D . A case-control study of deaths from asthma. Thorax. 1986; 41(11):833-9. PMC: 460507. DOI: 10.1136/thx.41.11.833. View

Newnham D, McDevitt D, Lipworth B . Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med. 1994; 97(1):29-37. DOI: 10.1016/0002-9343(94)90045-0. View

Nelson H, Weiss S, Bleecker E, Yancey S, Dorinsky P . The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006; 129(1):15-26. DOI: 10.1378/chest.129.1.15. View

Lofdahl C, Chung K . Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J. 1991; 4(2):218-26. View

. British Guideline on the Management of Asthma. Thorax. 2008; 63 Suppl 4:iv1-121. DOI: 10.1136/thx.2008.097741. View

10.

Grove A, Lipworth B . Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet. 1995; 346(8969):201-6. DOI: 10.1016/s0140-6736(95)91265-7. View

11.

Cheung D, Timmers M, Zwinderman A, Bel E, Dijkman J, Sterk P . Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992; 327(17):1198-203. DOI: 10.1056/NEJM199210223271703. View

12.

Sears M, Ottosson A, Radner F, Suissa S . Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J. 2008; 33(1):21-32. DOI: 10.1183/09031936.00145006. View

13.

Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, Fitzgerald J . Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1):143-78. DOI: 10.1183/09031936.00138707. View

14.

Nelson H . Beta-adrenergic bronchodilators. N Engl J Med. 1995; 333(8):499-506. DOI: 10.1056/NEJM199508243330807. View

15.

Ni Chroinin M, Greenstone I, Danish A, Magdolinos H, Masse V, Zhang X . Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev. 2005; (4):CD005535. DOI: 10.1002/14651858.CD005535. View

16.

Anderson H, Ayres J, Sturdy P, Bland J, Butland B, Peckitt C . Bronchodilator treatment and deaths from asthma: case-control study. BMJ. 2004; 330(7483):117. PMC: 544425. DOI: 10.1136/bmj.38316.729907.8F. View

17.

Castle W, Fuller R, Hall J, Palmer J . Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993; 306(6884):1034-7. PMC: 1676982. DOI: 10.1136/bmj.306.6884.1034. View

18.

Crane J, Pearce N, Burgess C, Woodman K, Robson B, Beasley R . Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992; 21(4):737-44. DOI: 10.1093/ije/21.4.737. View

19.

Arvidsson P, Larsson S, Lofdahl C, Melander B, SVEDMYR N, Wahlander L . Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J. 1991; 4(10):1168-73. View

20.

Greenstone I, Chroinin M, Masse V, Danish A, Magdalinos H, Zhang X . Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev. 2005; (4):CD005533. DOI: 10.1002/14651858.CD005533. View